ReviewPharmaceutics2022

Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy.

Ruogang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.